UPClytics
Alle Fälle anzeigen

UPC APP 23523/2024

·EP2681034: Device and method for continuous generative production

Verfahrensdetails
Status
Verfahrensart
Verfahrensantrag
Kategorie
Sonstige prozessuale
Parteien
Kläger
Vertreter: Wim Maas (Taylor Wessing); Alexander Rubusch (Taylor Wessing)
Beklagte
Vertreter: Philipp Neels (Eisenführ Speiser Rechts- und Patentanwälte, Hamburg)
Division
Paris CD
Richter
Technology
Pharmaceutical & Medical
Sprache
Erste Entscheidung
10. Mai 2024
Entscheidungen
  • 2024-05-10
    Generic application

    Paris Central Division procedural order (judge-rapporteur Haedicke) in a revocation action by CEAD B.V. and CEAD USA B.V. against BEGO Medical GmbH concerning EP 2 681 034 B1, addressing a request by CEAD (as claimant in the Dutch-language revocation proceedings) for simultaneous interpretation into Dutch (alternatively English) at the interim hearing (29 May 2024) and oral hearing (23 August 2024). The court rejected the request for simultaneous interpretation under R. 109 VerfO, holding that the right to be heard is sufficiently protected where the party's authorised representative is fluent in the language of the proceedings (German). Simultaneous interpretation at the parties' own cost, however, was permitted.

    Rechtsfragen:Request for simultaneous interpretation (R. 109 VerfO / Art. 51(2) UPCA)Right to be heard vs. language of proceedings requirementsCourt-ordered vs. party-funded interpretation
Dokumente
  • 875E6EB688D179A918197DD9FD96D501_de.pdf2024-05-10DE